Mochida Pharmaceutical Co., Ltd. (MFY) Financial Statements
Mochida Pharmaceutical Co., Ltd. Financial Overview
Mochida Pharmaceutical Co., Ltd.'s market cap is currently $634.07M. The company's EPS TTM is $259.26; its P/E ratio is 12.67; and it has a dividend yield of 2.46%. Mochida Pharmaceutical Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 116.95B | $ 105.16B | $ 102.89B | $ 103.26B | $ 110.18B |
| Gross Profit | $ 56.26B | $ 53.79B | $ 52.07B | $ 55.12B | $ 59.55B |
| Operating Income | $ 10.15B | $ 8.13B | $ 5.80B | $ 8.51B | $ 14.39B |
| EBITDA | $ 13.13B | $ 11.07B | $ 8.61B | $ 11.18B | $ 17.08B |
| Net Income | $ 7.90B | $ 5.68B | $ 4.55B | $ 6.65B | $ 10.57B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 31.06B | $ 51.15B | $ 46.79B | $ 60.51B | $ 61.91B |
| Total Assets | $ 182.72B | $ 163.56B | $ 162.30B | $ 161.04B | $ 165.93B |
| Total Debt | $ 10.00B | $ 342.00M | $ 369.00M | $ 178.00M | $ 0.00 |
| Net Debt | $ -18.06B | $ -44.81B | $ -32.92B | $ -46.83B | $ -48.41B |
| Total Liabilities | $ 42.39B | $ 32.87B | $ 34.33B | $ 34.26B | $ 37.28B |
| Stockholders' Equity | $ 140.33B | $ 130.69B | $ 127.97B | $ 126.78B | $ 128.65B |
| Cash Flow | |||||
| Free Cash Flow | $ -10.04B | $ 7.19B | $ -9.78B | $ 5.13B | $ 4.47B |
| Operating Cash Flow | $ -7.35B | $ 9.35B | $ -7.48B | $ 7.30B | $ 7.46B |
| Investing Cash Flow | $ -16.85B | $ 17.36B | $ 74.00M | $ -2.95B | $ -2.01B |
| Financing Cash Flow | $ 7.03B | $ -2.87B | $ -6.39B | $ -6.88B | $ -5.96B |
Currency in JPY
